Co-Authors
This is a "connection" page, showing publications co-authored by Celestino Sardu and Raffaele Marfella.
Connection Strength
4.748
-
Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy. J Am Heart Assoc. 2020 09; 9(17):e016948.
Score: 0.891
-
Hyperglycaemia on admission to hospital and COVID-19. Diabetologia. 2020 11; 63(11):2486-2487.
Score: 0.891
-
Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19. Cardiovasc Diabetol. 2020 06 11; 19(1):76.
Score: 0.887
-
Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? Diabetes Care. 2020 07; 43(7):1408-1415.
Score: 0.883
-
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction. Crit Care. 2021 06 24; 25(1):217.
Score: 0.238
-
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte. Cardiovasc Diabetol. 2021 05 07; 20(1):99.
Score: 0.236
-
Implications of AB0 blood group in hypertensive patients with covid-19. BMC Cardiovasc Disord. 2020 08 14; 20(1):373.
Score: 0.224
-
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes Metab. 2020 10; 46(5):403-405.
Score: 0.221
-
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. J Clin Med. 2020 May 11; 9(5).
Score: 0.220
-
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study. PLoS One. 2020; 15(12):e0243700.
Score: 0.057